| Structure |
Chemical Name |
CAS |
MF |
 |
4-(4-フルオロ-3-(ピペラジン-1-カルボニル)ベンジル)フタラジン-1(2H)-オン |
763111-47-3 |
C20H19FN4O2 |
 |
Trelagliptin Impurity 29 |
|
|
 |
D-Asn4-Carbetocin (Impurity F) |
|
|
 |
Riluzole 4-Bromo Impurity |
144631-82-3 |
C8H4BrF3N2OS |
 |
4-PYRIDINECARBOXIMIDIC ACID, HYDRAZIDE |
89830-71-7 |
C6H8N4 |
 |
Loratadine Impurity 19 |
79779-58-1 |
C22H24N2O2 |
 |
BRN 0758154 |
69304-48-9 |
C11H13IN2O5 |
 |
1,4-Butanediaminium, N1,N4-diethyl-N1,N1,N4,N4-tetrakis(1-methylethyl)-, bromide (1:2) |
1621467-18-2 |
C20H46BrN2+ |
 |
1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione |
2041584-99-8 |
C10H13FN2O5 |
 |
ClarithroMycin IMpurity G |
127182-44-9 |
C39H72N2O13 |
 |
Solifenacin impurity 18 |
1243274-83-0 |
C14H17NO3 |
 |
Phenacetin Impurity 3 |
24176-84-9 |
C14H13ClN2O2 |
![3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]-](/CAS/20150408/GIF/492444-39-0.gif) |
3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]- |
492444-39-0 |
C19H23ClN4O2 |
 |
Edaravone |
68195-63-1 |
C30H26N6O3 |
 |
Imatinib impurity 31 |
1356565-47-3 |
C17H17N7 |
 |
Tamsulosin impurity 6 |
|
C20H28N2O5S |
 |
Apixaban Impurity 48 |
|
|
 |
GLICLAZIDE IMPURITY B |
|
|
 |
4-Epi-6-epi Doxycycline |
97583-08-9 |
C22H24N2O8 |
 |
Crisaborole Impurity 10 |
|
|
 |
Dasatinib IMpurity 5 |
|
|
 |
Clarthromycin EP Impurity B |
299409-85-1 |
C37H67NO13 |
 |
-Oxo-a-propylenanthic Acid Ethyl Ester |
96610-56-9 |
C12H22O3 |
 |
Milnacipran Impurity 4 |
1353644-49-1 |
C15H21NO2 |
 |
Timolol EP Impurity J |
|
|
 |
1,4-ジヒドロ-2,6-ジメチル-4-(2-ニトロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-エチル |
53055-15-5 |
C18H20N2O6 |
 |
3-アセチルオキシ-2-ブテン酸エチル |
29214-62-8 |
C8H12O4 |
 |
Fenbendazole EP Impurity C |
|
|
![Quetiapine IMpurity P (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine fuMarate))](/CAS/20150408/GIF/1011758-03-4.gif) |
Quetiapine IMpurity P (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine fuMarate)) |
1011758-03-4 |
C19H21N3S |
 |
Procaine Impurity 2 |
|
C13H20N2O2 |
 |
Ixazomib Impurity ABCDEFGHJKL |
|
|
 |
Olaparib Impurity 24 |
|
|
 |
Moxifloxacin Impurity 2 |
|
|
 |
SalMeterol IMpurity F |
|
C25H37NO4 |
 |
(3S,5S)-Fluvastatin Sodium Salt |
194935-01-8 |
C24H27FNNaO4 |
 |
Afatinib impurity 82 |
|
|
 |
Cabozantinib Impurity D |
|
|
 |
rac 5-Keto Fluvastatin |
1160169-39-0 |
C24H24FNO4 |
 |
Fondaparinux sodium impurity 7 |
|
|
 |
Acrivastine Impurity 1 |
|
|
 |
Peramivir Impurity 3 |
|
|
 |
Apremilast Impurity TNB |
|
|
 |
Chrysophanol triglucoside |
120181-07-9 |
C33H40O19 |
 |
Everolimus impurity B |
|
|
 |
Caspofungin Impurity 11 |
|
|
 |
Apixaban iMpurity 1 |
|
|
 |
Irbesartan impurity A |
|
C25H28N6O |
 |
2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine |
1353428-89-3 |
C13H17NO |
 |
Mirabegron iMpurity |
1581285-26-8 |
C16H21ClN2 |
 |
3-オキソ-1,2-ベンゾイソチアゾリン-2-酢酸メチルエステル1,1-ジオキシド(PIROXICAM IMPURITY D)ピルオキシカム不純物D |
6639-62-9 |
C10H9NO5S |
 |
N-Trityl Candesartan Ethyl Ester |
856414-35-2 |
C45H38N6O3 |
 |
4-((2-amino-2-oxoethyl)amino)butanoic acid |
1096803-44-9 |
C6H12N2O3 |
 |
Sugammadex sodium Org244517-1 Impurity |
|
|
 |
Osimertinib Impurity 15 |
2945220-41-5 |
C56H66N14O4 |
 |
Azlocillin Opern-Ring Decarboxylation Impurity |
99795-14-9 |
C19H25N5O5S |
 |
Apremilast ImpurityTNN |
|
|
 |
Dolutegravir Impurity 16 |
1357289-37-2 |
C20H19F2N3O5 |
 |
Cefoxitin Impurity |
|
|
 |
(2S)-2-ピロリジンカルボン酸エチル |
5817-26-5 |
C7H13NO2 |
 |
Nicergoline Impurity 7 |
|
|
![alpha-Hydroxy-alpha-phenylbenzeneacetic acid (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride](/CAS/GIF/63516-30-3.gif) |
alpha-Hydroxy-alpha-phenylbenzeneacetic acid (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride |
63516-30-3 |
C21H23NO3.ClH |
 |
4-(2-Chloroethyl)-N-methoxy-N,α,α-trimethyl-benzeneacetamide |
1638785-17-7 |
C14H20ClNO2 |
 |
Levosimendan Impurity 8 |
274263-65-9 |
C14H14N6O2 |
 |
17,21-ジヒドロキシ-6α-メチルプレグナ-1,4-ジエン-3,11,20-トリオン |
91523-05-6 |
C22H28O5 |
![1H-Indole-2-carboxamide, 1-[(1S,2S)-1-[(Z)-amino(hydroxyimino)methyl]-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-](/CAS/20240320/GIF/3047556-95-3.gif) |
1H-Indole-2-carboxamide, 1-[(1S,2S)-1-[(Z)-amino(hydroxyimino)methyl]-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]- |
3047556-95-3 |
C28H34N4O3 |
 |
Venlafaxine |
3107597-43-0 |
C17H27NO2 |
 |
1-ニトロ-3,7-ジメチルアダマンタン |
6588-68-7 |
C12H19NO2 |
 |
Mupirocin iMpurity F |
|
C26H44O9 |
 |
Vildagliptin Dione Impurity |
1844894-70-7 |
C17H24N2O3 |
 |
L-erythro-Hexuronic acid, 3,5-dideoxy-, 1,1-dimethylethyl ester |
1501982-84-8 |
C10H18O5 |
 |
Rosuvastatin Impurity 59 |
|
|
 |
1-(2-chloro-2-(2,4-difluorophenyl)ethyl)-1H-1,2,4-triazole |
206050-24-0 |
C10H8ClF2N3 |
![AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO](/CAS/20211123/GIF/1642629-94-4.gif) |
AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO |
1642629-94-4 |
C16H21N3O6S |
 |
Moxifloxacin Impurity 6 |
849770-49-6 |
C25H29BFN3O8 |
 |
BrivaracetamImpurity ABCDEFGHJKL |
|
|
![Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]-](/CAS/20211123/GIF/1404083-47-1.gif) |
Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]- |
1404083-47-1 |
C52H86N10O16 |
 |
Doxofylline Impurity 14 |
|
|
 |
Itraconazole iMpurity A |
|
|
![rac 4-[4-(Oxiranylmethoxy)-1,2,5-thiadiazol-3-yl]morpholine](/CAS/GIF/58827-68-2.gif) |
rac 4-[4-(Oxiranylmethoxy)-1,2,5-thiadiazol-3-yl]morpholine |
58827-68-2 |
C9H13N3O3S |
 |
Apixaban Impurity 20 |
1421823-20-2 |
C27H29ClN4O5 |
 |
Citalopram Related Compound F |
|
|
 |
bortezoMib iMpurity F |
|
|
![5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン](/CAS/GIF/951624-49-0.gif) |
5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン |
951624-49-0 |
C13H11FN4O |
 |
2-メチルプロパンボロン酸(1S,2S,3R,5S)-(+)-2,3-ピナンジオールエステル |
84110-34-9 |
C14H25BO2 |
 |
Solifenacin N-Oxide |
180272-28-0 |
C23H26N2O3 |
 |
5-phenyl-1H-pyrrole-3-carbonitrile |
122453-85-4 |
C11H8N2 |
 |
N2-Methyl Alfuzosin Hydrochloride |
72104-34-8 |
C19H28ClN5O4 |
![D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel-](/CAS/20210305/GIF/2740644-40-8.gif) |
D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel- |
2740644-40-8 |
C14H22N2O6 |
 |
Flomoxef Impurity 2 |
|
|
 |
Telmisartan EP-J |
885045-90-9 |
C33H29ClN4O2 |
 |
Dapagliflozin mono acetyl impurity |
1632287-34-3 |
C23H27ClO7 |
 |
Benazepril Impurity E |
|
C24H28N2O5 |
 |
Sitagliptin Impurity 77 |
382638-00-8 |
C11H21NO7S |
 |
N-(4-(4-fluorophenyl)-5-((E)-2-((2R,4R)-4-hydroxy-6- oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin- 2-yl)-N-methylmethanesulfonamide |
|
C22H26FN3O5S |
 |
Cabozantinib impurity 52 |
|
|
 |
Ticagrelor Impurity 124 |
|
|
 |
1-(5-(benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone |
861841-94-3 |
C15H13NO5 |
 |
Lenvatinib Impurity 42 |
|
|
 |
Betaxolol EP Impurity E |
1329613-85-5 |
C18H31NO3 |
![5-[2-Ethoxy-5-[(4-Methyl-1-piperazinyl)thioxoMethyl]phenyl]-1,6-dihydro-1-Methyl-3-propyl-7H-pyrazolo[4,3-d]pyriMidine-7-thione](/CAS/20150408/GIF/1333233-46-7.gif) |
5-[2-Ethoxy-5-[(4-Methyl-1-piperazinyl)thioxoMethyl]phenyl]-1,6-dihydro-1-Methyl-3-propyl-7H-pyrazolo[4,3-d]pyriMidine-7-thione |
1333233-46-7 |
C23H30N6OS2 |